Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 EP958 | DOI: 10.1530/endoabs.81.EP958

1Hedi Chaker University Hospital, Department of Endocrinology, Sfax, Tunisia; 2Hedi Chaker University Hospital, Department of Human Genetics, Sfax, Tunisia


Introduction: Polyglandular autoimmune syndrome (PAS) are uncommon constellations of autoimmune diseases characterized by the occurrence of two or more auto-immune endocrine diseases in the same individual.

Patients and methods: It is a case-control study about 108 cases for 120 healthy subjects recruited as the control group. We aimed to study the polymorphism of the HLA class-II genes of patients compared to that of healthy subjects so as to identify the genetic susceptibility to PAS.

Results: Among 108 patients, 2 patients had PAS type I (PAS-I), 39 patients had the type II (PAS-II) and 67 patients had the type III (PAS-III). Thirteen patients with PAS-II against 120 healthy subjects in the control group were included for the genetic testing of HLA class-II allele. DRB1*03 allele was associated with the occurrence of PAS-II whereas DRB1*13 was detected in only one patient but in 40 subjects expressing a negative association of this allele with PAS-II but remains statistically insignificant. We also found the association of DQB1*0302 in our population (P=0.004). DQB1*06 is a protective allele more prevalent in healthy subjects (22.97%) than in patients (3.8%) (P=0.023) but this difference becomes insignificant after Bonferroni correction. Twenty-seven patients with PAS-III were tested for HLA class-II alleles. DRB1*03 allele was found to be associated with PAS-III (P=0.0001) whereas no association was noted with DRB1*04 allele (P=0.22). DRB1*13 allele was found in 5 patients and 40 subjects in favor of the negative association of this allele in PAS-III (P=0.11). A significant association was also observed with DQB1*02 allele in our population (P=0.0034). In all, 40 patients with PAS-II/III were tested for HLA class-II alleles and demonstrated the association of PAS-II/III with DRB1*03 allele (P=0.0021) but a less significant association was noted with DRB1*04 (P=0.05). As far as protective DRB1*13 and DQB1*06 alleles are concerned, we noticed a negative association but insignificant after correction in PAS.

Discussion and Conclusion: The genetics of PAS is based essentially on the association of certain alleles of the human major histocompatibility complex. The presence of susceptibility alleles DRB1*03 and DQB1*0302 is described in literature. However, some studies showed the association of DR4-DQB1*0302 with PAS-II or III is due entirely to the presence of pancreatic auto-antibodies whereas haplotype DR3-DQB1*0201 is associated not only with type-1 diabetes mellitus but also PAS-II/III in the absence of pancreatic autoantibodies. The study of genetics have evolved considerably during the last years, especially due to molecular biology techniques.

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts